Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paraneoplastic syndrome]

Y Nakanishi1, K Takayama, N Hara

  • 1Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 25, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel method of drug delivery for fibrinolysis with Ho:YAG laser-induced liquid jet.

Lasers in medical science·2002
Same author

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.

Gene therapy·2002
Same author

Molecular genotyping of isolates of Actinobacillus actinomycetemcomitans by pulsed-field gel electrophoresis after separate digestion with Sse8387I and XhoI.

Journal of basic microbiology·2002
Same author

The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.

Journal of controlled release : official journal of the Controlled Release Society·2002
Same author

Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.

Drug development and industrial pharmacy·2002
Same author

Detection of early venous filling in gliomas on MRI: preliminary study by 2D time-resolved dynamic contrast-enhanced MR angiography with echo-sharing technique.

Magnetic resonance imaging·2002

Treating paraneoplastic syndromes in lung cancer focuses on controlling the underlying cancer. Management strategies vary, including surgery for Cushing's syndrome and fluid restriction for syndrome of inappropriate antidiuretic hormone secretion.

Area of Science:

  • Oncology
  • Endocrinology
  • Nephrology

Background:

  • Paraneoplastic syndromes are complex conditions associated with lung cancer.
  • Effective management requires addressing both the syndrome and the primary malignancy.

Purpose of the Study:

  • To review current treatment strategies for paraneoplastic syndromes in lung cancer patients.
  • To highlight the importance of treating the underlying cancer.

Main Methods:

  • Literature review of established and investigational treatments for paraneoplastic syndromes.
  • Focus on endocrine and electrolyte disturbances commonly seen with lung cancer.

Main Results:

  • Surgical tumor resection is the primary treatment for operable Cushing's syndrome.

Related Experiment Videos

  • Fluid restriction is standard for syndrome of inappropriate antidiuretic hormone secretion; demeclocycline and hypertonic saline are alternatives.
  • Pamidronate and calcitonin manage hypercalcemia; heparin is used for disseminated intravascular coagulation with controversial efficacy.

    • Conclusions:

    • Treatment of paraneoplastic syndromes necessitates a multi-faceted approach targeting the underlying lung cancer and specific symptoms.
    • Further research is needed for optimal management of certain paraneoplastic manifestations.